Document is current
Any future updates will be listed below
-
Authors
Guilleminault, Laurent http://orcid.org/0000-0002-7344-8290
Michelet, Marine
Reber, Laurent Lionel http://orcid.org/0000-0003-3384-6769
- License Information
-
More Information
Article History
Accepted: 10 September 2021
First Online: 22 September 2021
Declarations
:
: L.G. has been an investigator in clinical trials for AstraZeneca, MSD, and Novartis and reports grants or fees for consulting from AstraZeneca, GlaxoSmithKline, Novartis, and Sanofi-Regeneron and fees for consulting from Bayer, Chiesi, MSD, not related to the submitted work. M.M. declares no disclosure of interest. L.L.R. reports grants or consulting fees from Neovacs S.A. not related to the work submitted, and patents issued or pending relating to allergy diagnosis or therapy: 63/079,686, PCT/EP2021/060829, WO2019197607 (A1) and WO2019228674 (A1).
